Short-chain fatty acids in patients with schizophrenia and ultra-high risk population.
Frontiers in psychiatry(2022)
Abstract
Our study suggests that alterations in concentrations of SCFAs may be associated with the pathogenesis and the cognitive impairment of schizophrenia. Further researches are warranted to explore this association. The clinical implications of our findings were discussed.
MoreTranslated text
Key words
caproic acid,schizophrenia,short-chain fatty acid,ultra-high-risk population,valeric acid
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined